Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers
Year: 2007
Type: article
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd2251
Institution: Massachusetts Institute of Technology
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2015121141